AMRN Competitors
Amarin Corporation plc
$11.62
+$0.01(+0.09%)
49
Overall
60
Value
36
Tech
52
Quality
Market Cap
$245.24M
Volume
29.73K
52W Range
$11.83 - $20.90
Target Price
$13.00
AMRN competitors: ABBV, TEVA, ALKS, GSK, AZN. Amarin Corporation plc is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMRN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| ABBV AbbVie Inc. | $283.48 | $500.94B | $13.94 | 2.41% | 70 |
| TEVA Teva Pharmaceutical Industries Limited | $40.72 | $47.45B | $1.94 | - | 72 |
| ALKS Alkermes plc | $39.08 | $6.56B | $-0.56 | 2.74% | 49 |
| GSK GSK plc | $47.87 | $94.64B | $4.78 | 3.79% | 33 |
| AZN AstraZeneca PLC | $162.03 | $244.56B | $9.36 | 1.48% | 61 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRN | $11.62 | +0.1% | 29.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |